In8bio
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $3,748 |
Gross Profit | -631 | -632 | 3,121 |
EBITDA | -7,998 | -8,013 | -7,301 |
EBIT | -8,629 | -8,645 | -7,928 |
Net Income | -8,629 | -8,562 | -7,598 |
Net Change In Cash | 0 | 0 | 3,748 |
Free Cash Flow | -6,174 | -7,990 | -4,922 |
Cash | 10,217 | 13,015 | 21,282 |
Basic Shares | 45,126 | 43,290 | 35,801 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2,501 | -1,103 | -251 | -96 |
EBITDA | -28,504 | -27,418 | -14,402 | -8,469 |
EBIT | -30,337 | -28,521 | -14,653 | -8,565 |
Net Income | -30,007 | -27,418 | -14,653 | -8,557 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -23,940 | -27,826 | -13,818 | -7,133 |
Cash | 21,282 | 18,182 | 37,021 | 17,994 |
Basic Shares | 29,864 | 20,967 | 18,781 | 19,354 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.15 |
2024-06-30 | -$0.19 |
2024-03-31 | -$0.20 |
2023-12-31 | -$0.21 |
